Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 7,300 shares at $25.45 ($186K) on 2024-11-20, disclosed to the SEC on 2024-11-22.
Open-market sale of $186k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.45 | 3,650 | $93K | 50.0% |
| 2 | $25.45 | 3,650 | $93K | 50.0% |
| Total | $25.45 avg | 7,300 | $186K | 100% |
| Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |
| IMVT | SELL | 2024-07-19 | $144K | — | Filing → |